|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.970 USD | -1.98% |
|
-10.52% | -69.47% |
| 06-30 | Plus Therapeutics, Inc. - Special Call | |
| 06-30 | Plus Therapeutics Advances REYOBIQ Clinical Trials and Manufacturing Progress | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 27.88M | - | - | - | ||
| 50.25B | |||||
| 40.39B | - | - | - | - | - |
| 34.38B | |||||
| 34.4B | |||||
| 26.32B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
